|
CHOP Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: CHOP protocol, Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone
Pipeline
Phase 2: 1Phase 3: 2
Top Sponsors
- Sherief Abd-Elsalam1
- National Cancer Institute (NCI)1
- Acrotech Biopharma Inc.1
Indications
- Cancer3
- NHL1
- Peripheral T Cell Lymphoma1
- DLBCL1
- Non-Hodgkin's Lymphoma1
Other1 trial
Clovis, California1 trial
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
University of California, San Francisco Fresno
Phase 3
Bethesda, Maryland1 trial
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
National Institutes of Health Clinical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.